Navigation Links
Get the Facts on the Albuterol Inhaler Transition

Allergy & Asthma Network Mothers of Asthmatics Applauds FDA Public Health

Advisory and Offers Critical Facts Patients Need to Know

FAIRFAX, Va., May 30 /PRNewswire-USNewswire/ -- Millions of asthma patients and their healthcare providers do not know that at the end of this year, their life-saving medications will be gone. Today, FDA urged patients still using chlorofluorocarbon (CFC) albuterol metered-dose inhalers (MDIs) to switch to alternate hydrofluoroalkane (HFA) inhalers (albuterol and levalbuterol) before CFCs are completely off the market. As of December 31, 2008, no CFC albuterol inhalers will be manufactured or sold in this country.

CFC is used to propel medication from asthma inhalers into patients' airways. But it also depletes the earth's ozone layer, so it's being phased out of medications like inhaled albuterol, one of the top 10 prescriptions written in the United States. Patients with asthma, COPD and other respiratory conditions use albuterol at the first sign of symptoms, before exercise and when experiencing breathing exacerbations. Alternate inhalers using HFA as a propellant are replacing CFC albuterol.

"We applaud FDA's efforts to educate patients and medical professionals about the new HFA inhalers," states Nancy Sander, president and founder of Allergy & Asthma Network Mothers of Asthmatics (AANMA). "There are critical differences between CFC and HFA inhalers that patients need to know in order to use these medications properly."

-- HFA MDIs have a softer spray. Some patients comment that force of the

HFA propellant is not strong enough to "push open" their airways during

an attack. But it is the correct inhalation technique, not the force of

the propellant, that determines how well the medication works. Neither

type of inhaler can push or force airways open.

-- HFA MDIs have different cleaning requirements. HFA MDIs need to be

cleaned more frequently than CFC MDIs. HFAs tend to clog more quickly

than CFCs, preventing medication from reaching patients' airways.

-- HFA MDIs have different priming requirements. Priming (spraying

multiple doses into the air) loads the correct dose of medication

inside the inhaler. Each HFA inhaler has different priming

instructions, which can be quite different from CFC priming.

-- HFA MDIs offer more treatment options. In the past, all brand and

generic albuterol CFC MDIs were virtually identical. Now there are

three uniquely different formulations of albuterol HFA inhalers plus a

levalbuterol HFA inhaler -- each distinctly different from the others.

Some people may find that one HFA inhaler works better for them than


-- HFA MDIs cost more than generic CFC albuterol MDIs. HFA MDIs are not

simply copies of CFC MDIs with new propellants. The inhaler transition

required a complete overhaul of the MDI manufacturing process. No

generic HFA MDIs are currently available. This translates to higher

out-of-pocket expenses for many patients, even those with prescription

drug coverage. Pharmaceutical companies are providing financial

assistance to patients in the form of rebates, discounts and coupons

and patient assistance programs.

"These are lifesaving medications," says Sander. "Patients and medical professionals need to know that inhalers are changing and have the opportunity to make the switch in a medically responsible way. Our advice to patients: Get the facts. Know your options. Make informed choices."

Visit AANMA's MDI Transition Web page at for more information.

Founded in 1985, Allergy & Asthma Network Mothers of Asthmatics is the leading national nonprofit family organization dedicated to eliminating suffering and death due to asthma, allergies and related conditions. AANMA's core areas of expertise are education, advocacy and outreach. Call 800.878.4403 or visit

SOURCE Allergy & Asthma Network Mothers of Asthmatics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA: Use the Nutrition Facts Label to Make Healthy Food Choices
2. NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains
3. MRSA Facts for Handwashing Week
4. Face facts: People dont stand out in crowds
5. Flu and Fever Detection Facts for Dr. Mom
6. Medifacts Systems, Inc. Grants Exclusive License for Genetic Test Patent to Mayo Clinic
7. The Facts African Americans Need to Know About Colon Cancer
8. During National Nutrition Month and Beyond, Find the Facts on Nutrition by Focusing on the Science
9. One-Third of Parents Lack Facts About Child Development
10. Inhaler Eased Lung Problems in 9/11 Workers
11. Germ-Fighting Inhaler Could Fend Off Bioterror Agents
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch ... solutions involving adult stem cell therapies to patients with chronic degenerative medical conditions. ... as a Registered Trademark (RTM). , Organizations are required to hold a registered ...
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA , ... now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. This ... cutting tools, such as the scalpel and high-speed drill, which can both cause patients ...
(Date:11/24/2015)... Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... explored the different restrictions and variables that determine which patients are or are not ... those patients that have a BMI over 40, are more than 100 pounds overweight, ...
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 --> ... eine Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, ... ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... Leben gerufenen und von Edelris gemeinsam mit seinen Partnern ... Behandlungsziel für HBV identifiziert, und es wurden neue Inhaltsstoffe ...
(Date:11/24/2015)... 24, 2015  Natera, Inc. (Nasdaq: ... testing and the analysis of circulating cell-free ... at the 27 th  Annual Piper Jaffray ... p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of Natera, ... activities and financial outlook.  ...
(Date:11/24/2015)... York , 24. November 2015 /PRNewswire/ ... Avery Breathing Pacemaker Systems, ist erfreut, die ... Clinical Consultant bekannt geben zu können. ...   --> Foto - ... (Schweden). Von 1984-1986 war er ...
Breaking Medicine Technology: